Skip to main content
OpenTrials

Clinical trial condition

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Explore clinical trials studying Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) trial results

Recruiting

Phase II Study of RC1416 Injection in COPD

NCT07402551

Conditions
Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Locations
  • Anhui Provincial Chest Hospital Hefei, Anhui, China
  • Wan Bei General Hospital of Wanbei Coal power Group Suzhou, Anhui, China
  • The Affiliated Bishan Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Zhongshan Hospital Xiamen University Xiamen, Fujian, China
View all 42 locations
View Trial Details
Completed

Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD

NCT01584505

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +6 more
Locations
  • Hospital "Lozenets" Sofia, Bulgaria
  • Praxis Dr. Kampschulte Berlin, Germany
  • Fővárosi Önkormányzat Szent János Kórháza és Észak-budai Egyesített Kórházai Tüdőgondozó Szakrendelő Budapest, Hungary
  • ISPL Centrum Medyczne Robert M. Mróz Bialystok, Poland
View Trial Details
Active, Not Recruiting

Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).

NCT06175351

Conditions
Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Locations
  • Baogang Hospital (No 3 Hospital Affiliated to Medical College of Inner Mongolia) Baotou, China
  • China-Japan Friendship Hospital Beijing, China
  • Peking University Shougang Hospital Beijing, China
  • The First Hospital of Changsha Changsha, China
View all 22 locations
View Trial Details

Related conditions